Search Results
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
NeoBase 2 Non-derivatized MSMS kit
NeoBase™ 2 kit, The next generation in MSMS based newborn screening for detecting more than 30 different metabolic diseases from a single dried blood spot sample using a MSMS tandem mass spectrometer.
NeoBase™ 2 MSMS kit may not be available in all countries, such as Canada. Please check out availability with your local Revvity representative.
Product information
Overview
The next generation in tandem mass spectrometry based newborn screening, the NeoBase™ 2 Non-derivatized MSMS kit gives you the ability to screen for all the common acid, organic acid and fatty acid oxidation.
- For more than 50 analytes, including markers for screening of x-ald and ada scid, from a single DBS punch with a single extraction and incubation step.
- A reformulated flow solvent that improves ionization and makes it easy to switch between the NeoLSD™ kit and NeoBase™ 2 kit
- DBS quality controls with analyte concentrations adjusted at clinically significant levels
- All internal standards are in a single vial making reconstitution easy. Extraction solution is stable for up to two weeks, eliminating the need for daily preparation.
- Shorter extraction time, shorter incubation time and shorter run time
- New specific markers for urea cycle disorders asa-ld, otcd, cps-i and nags as well as for ADA SCID providing more conclusive screening results
Specifications
| Application |
Newborn Screening
|
|---|---|
| Brand |
NeoBase™ 2
|
| Detection Method |
Mass Spectrometry (MSMS)
|
| Disorders |
Metabolic Disorders
|
SDS, COAs, Manuals and more
Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.
Related products
of 2
How can we help you?
We are here to answer your questions.
